Malario (Esperanto Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malario" in Esperanto language version.

refsWebsite
Global rank Esperanto rank
2nd place
7th place
3rd place
6th place
195th place
64th place
1st place
1st place
218th place
212th place
low place
low place
301st place
24th place
low place
low place
8th place
19th place
24th place
33rd place
low place
9,863rd place
low place
3,219th place
low place
low place
low place
low place
2,769th place
2,262nd place
low place
low place
2,569th place
613th place
1,791st place
465th place
low place
low place
2,374th place
3,693rd place
234th place
108th place
782nd place
410th place
197th place
136th place
9,300th place
7,138th place
low place
low place
857th place
172nd place
low place
low place
1,226th place
966th place
249th place
415th place
6th place
25th place
7th place
13th place
79th place
187th place
49th place
103rd place
279th place
26th place
1,389th place
671st place
low place
low place
low place
low place
low place
low place
1,293rd place
333rd place
99th place
284th place

admin.ch

dfae.admin.ch

ajtmh.org

archive.org

army.mil

history.amedd.army.mil

bbc.co.uk

bbc.co.uk

news.bbc.co.uk

  • "DNA clues to malaria in ancient Rome", BBC News, February 20, 2001. , in reference to Sallares R, Gomzi S (2001). “Biomolecular archaeology of malaria”, Ancient Biomolecules 3 (3), p. 195–213. 

bloomberg.com

bmj.com

books.google.com

cdc.gov

cdc.gov

wwwnc.cdc.gov

doi.org

doi.org

  • Greenwood, Brian M.; Kalifa Bojang; Christopher J. M. Whitty; Geoffrey A. T. Targett (2005). “Malaria”, The Lancet 365 (9469), p. 1487–1498. doi:10.1016/s0140-6736(05)66420-3. 
  • (2005) “Is malaria a disease of poverty? A review of the literature”, Tropical Health and Medicine 10 (10), p. 1047–59. doi:10.1111/j.1365-3156.2005.01476.x. 
  • Greenwood BM, Bojang K, Whitty CJ, Targett GA (2005). “Malaria”, Lancet 365 (9469), p. 1487–98. doi:10.1016/S0140-6736(05)66420-3. 
  • Nadjm B, Behrens RH (2012). “Malaria: An update for physicians”, Infectious Disease Clinics of North America 26 (2), p. 243–59. doi:10.1016/j.idc.2012.03.010. 
  • Bartoloni A, Zammarchi L (2012). “Clinical aspects of uncomplicated and severe malaria”, Mediterranean Journal of Hematology and Infectious Diseases 4 (1), p. e2012026. doi:10.4084/MJHID.2012.026. 
  • Taylor WR, Hanson J, Turner GD, White NJ, Dondorp AM (2012). “Respiratory manifestations of malaria”, Chest 142 (2), p. 492–505. doi:10.1378/chest.11-2655. 
  • Korenromp E, Williams B, de Vlas S, Gouws E, Gilks C, Ghys P, Nahlen B (2005). “Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa”, Emerging Infectious Diseases 11 (9), p. 1410–9. doi:10.3201/eid1109.050337. 
  • Beare NA, Lewallen S, Taylor TE, Molyneŭ ME (2011). “Redefining cerebral malaria by including malaria retinopathy”, Future Microbiology 6 (3), p. 349–55. doi:10.2217/fmb.11.3. 
  • Hartman TK, Rogerson SJ, Fischer PR (2010). “The impact of maternal malaria on newborns”, Annals of Tropical Paediatrics 30 (4), p. 271–82. doi:10.1179/146532810X12858955921032. 
  • Rijken MJ, McGready R, Boel ME, Poespoprodjo R, Singh N, Syafruddin D, Rogerson S, Nosten F (2012). “Malaria in pregnancy in the Asia-Pacific region”, Lancet Infectious Diseases 12 (1), p. 75–88. doi:10.1016/S1473-3099(11)70315-2. 
  • Mueller I, Zimmerman PA, Reeder JC (2007). “Plasmodium malariae and Plasmodium ovale—the "bashful" malaria parasites”, Trends in Parasitology 23 (6), p. 278–83. doi:10.1016/j.pt.2007.04.009. 
  • Collins WE (2012). “Plasmodium knowlesi: A malaria parasite of monkeys and humans”, Annual Review of Entomology 57, p. 107–21. doi:10.1146/annurev-ento-121510-133540. 
  • Sarkar PK, Ahluwalia G, Vijayan VK, Talwar A (2009). “Critical care aspects of malaria”, Journal of Intensive Care Medicine 25 (2), p. 93–103. doi:10.1177/0885066609356052. 
  • Baird JK (2013). “Evidence and implications of mortality associated with acute Plasmodium vivax malaria”, Clinical Microbiology Reviews 26 (1), p. 36–57. doi:10.1128/CMR.00074-12. 
  • Arnott A, Barry AE, Reeder JC (2012). “Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination”, Malaria Journal 11, p. 14. doi:10.1186/1475-2875-11-14. 
  • Collins WE, Barnwell JW (2009). “Plasmodium knowlesi: finally being recognized”, Journal of Infectious Diseases 199 (8), p. 1107–8. doi:10.1086/597415. 
  • Cowman AF, Berry D, Baum J (2012). “The cellular and molecular basis for malaria parasite invasion of the human red blood cell”, Journal of Cell Biology 198 (6), p. 961–71. doi:10.1083/jcb.201206112. 
  • Owusu-Ofori AK, Parry C, Bates I (2010). “Transfusion-transmitted malaria in countries where malaria is endemic: A review of the literature from sub-Saharan Africa”, Clinical Infectious Diseases 51 (10), p. 1192–8. doi:10.1086/656806. 
  • White NJ (2011). “Determinants of relapse periodicity in Plasmodium vivax malaria”, Malaria Journal 10, p. 297. doi:10.1186/1475-2875-10-297. 
  • Tran TM, Samal B, Kirkness E, Crompton PD (2012). “Systems immunology of human malaria”, Trends in Parasitology 28 (6), p. 248–57. doi:10.1016/j.pt.2012.03.006. 
  • Bledsoe GH (2005). “Malaria primer for clinicians in the United States”, Southern Medical Journal 98 (12), p. 1197–204; quiz 1205, 1230. doi:10.1097/01.smj.0000189904.50838.eb. 
  • Vaughan AM, Aly AS, Kappe SH (2008). “Malaria parasite pre-erythrocytic stage infection: Gliding and hiding”, Cell Host & Microbe 4 (3), p. 209–18. doi:10.1016/j.chom.2008.08.010. 
  • Richter J, Franken G, Mehlhorn H, Labisch A, Häussinger D (2010). “What is the evidence for the existence of Plasmodium ovale hypnozoites?”, Parasitology Research 107 (6), p. 1285–90. doi:10.1007/s00436-010-2071-z. 
  • Tilley L, Dixon MW, Kirk K (2011). “The Plasmodium falciparum-infected red blood cell”, International Journal of Biochemistry and Cell Biology 43 (6), p. 839–42. doi:10.1016/j.biocel.2011.03.012. 
  • Mens PF, Bojtor EC, Schallig HDFH (2012). “Molecular interactions in the placenta during malaria infection”, European Journal of Obstetrics & Gynecology and Reproductive Biology 152 (2), p. 126–32. doi:10.1016/j.ejogrb.2010.05.013. 
  • Rénia L, Wu Howland S, Claser C, Charlotte Gruner A, Suwanarusk R, Hui Teo T, Russell B, Ng LF (2012). “Cerebral malaria: mysteries at the blood-brain barrier”, Virulence 3 (2), p. 193–201. doi:10.4161/viru.19013. 
  • Kwiatkowski DP (2005). “How malaria has affected the human genome and what human genetics can teach us about malaria”, American Journal of Human Genetics 77 (2), p. 171–92. doi:10.1086/432519. 
  • Hedrick PW (2011). “Population genetics of malaria resistance in humans”, Heredity 107 (4), p. 283–304. doi:10.1038/hdy.2011.16. 
  • Weatherall DJ (2008). “Genetic variation and susceptibility to infection: The red cell and malaria”, British Journal of Haematology 141 (3), p. 276–86. doi:10.1111/j.1365-2141.2008.07085.x. 
  • Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P (2011). “Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries”, Cochrane Database of Systematic Reviews (7), p. CD008122. doi:10.1002/14651858.CD008122.pub2. 
  • Kattenberg JH, Ochodo EA, Boer KR, Schallig HD, Mens PF, Leeflang MM (2011). “Systematic review and meta-analysis: Rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women”, Malaria Journal 10, p. 321. doi:10.1186/1475-2875-10-321. 
  • Wilson ML (2012). “Malaria rapid diagnostic tests”, Clinical Infectious Diseases 54 (11), p. 1637–41. doi:10.1093/cid/cis228. 
  • Perkins MD, Bell DR (2008). “Working without a blindfold: The critical role of diagnostics in malaria control”, Malaria Journal 1 (Suppl 1), p. S5. doi:10.1186/1475-2875-7-S1-S5. 
  • Sabot O, Cohen JM, Hsiang MS, Kahn JG, Basu S, Tang L, Zheng B, Gao Q, Zou L, Tatarsky A, Aboobakar S, Usas J, Barrett S, Cohen JL, Jamison DT, Feachem RG (2010). “Costs and financial feasibility of malaria elimination”, Lancet 376 (9752), p. 1604–15. doi:10.1016/S0140-6736(10)61355-4. 
  • (13a de Januaro 2015) “Intermittent preventive antimalarial treatment for children with anaemia.”, The Cochrane database of systematic reviews 1, p. CD010767. doi:10.1002/14651858.CD010767.pub2. 
  • Lengeler C (2004). “Insecticide-treated bed nets and curtains for preventing malaria”, Cochrane Database of Systematic Reviews (2), p. CD000363. doi:10.1002/14651858.CD000363.pub2. 
  • Tanser FC, Lengeler C, Sharp BL (2010). “Indoor residual spraying for preventing malaria”, Cochrane Database of Systematic Reviews (4), p. CD006657. doi:10.1002/14651858.CD006657.pub2. 
  • Raghavendra K, Barik TK, Reddy BP, Sharma P, Dash AP (2011). “Malaria vector control: From past to future”, Parasitology Research 108 (4), p. 757–79. doi:10.1007/s00436-010-2232-0.  [rompita ligilo]
  • Howitt P, Darzi A, Yang GZ, Ashrafian H, Atun R, Barlow J, Blakemore A, Bull AM, Car J, Conteh L, Cooke GS, Ford N, Gregson SA, Kerr K, King D, Kulendran M, Malkin RA, Majeed A, Matlin S, Merrifield R, Penfold HA, Reid SD, Smith PC, Stevens MM, Templeton MR, Vincent C, Wilson E (2012). “Technologies for global health”, The Lancet 380 (9840), p. 507–35. doi:10.1016/S0140-6736(12)61127-1. 
  • Miller JM, Korenromp EL, Nahlen BL, W Steketee R (2007). “Estimating the number of insecticide-treated nets required by African households to reach continent-wide malaria coverage targets”, Journal of the American Medical Association 297 (20), p. 2241–50. doi:10.1001/jama.297.20.2241. 
  • Noor AM, Mutheu JJ, Tatem AJ, Hay SI, Snow RW (2009). “Insecticide-treated net coverage in Africa: Mapping progress in 2000–07”, Lancet 373 (9657), p. 58–67. doi:10.1016/S0140-6736(08)61596-2. 
  • Enayati A, Hemingway J (2010). “Malaria management: Past, present, and future”, Annual Review of Entomology 55, p. 569–91. doi:10.1146/annurev-ento-112408-085423. 
  • van den Berg H (2009). “Global status of DDT and its alternatives for use in vector control to prevent disease”, Environmental Health Perspectives 117 (11), p. 1656–63. doi:10.1289/ehp.0900785. 
  • Pates H, Curtis C (2005). “Mosquito behaviour and vector control”, Annual Review of Entomology 50, p. 53–70. doi:10.1146/annurev.ento.50.071803.130439. 
  • Tusting LS, Thwing J, Sinclair D, Fillinger U, Gimnig J, Bonner KE, Bottomley C, Lindsay SW (2013). “Mosquito larval source management for controlling malaria”, Cochrane Database of Systematic Reviews 8, p. CD008923. doi:10.1002/14651858.CD008923.pub2. 
  • Enayati AA, Hemingway J, Garner P. (2007). “Electronic mosquito repellents for preventing mosquito bites and malaria infection”, Cochrane Database of Systematic Reviews (PDF) (2), p. CD005434. doi:10.1002/14651858.CD005434.pub2. 
  • Jacquerioz FA, Croft AM (2009). “Drugs for preventing malaria in travellers”, Cochrane Database of Systematic Reviews (4), p. CD006491. doi:10.1002/14651858.CD006491.pub2. 
  • Freedman DO (2008). “Clinical practice. Malaria prevention in short-term travelers”, New England Journal of Medicine 359 (6), p. 603–12. doi:10.1056/NEJMcp0803572. 
  • Fernando SD, Rodrigo C, Rajapakse S (2011). “Chemoprophylaxis in malaria: Drugs, evidence of efficacy and costs”, Asian Pacific Journal of Tropical Medicine 4 (4), p. 330–6. doi:10.1016/S1995-7645(11)60098-9. 
  • (Oct 10, 2014) “Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.”, The Cochrane database of systematic reviews 10, p. CD000169. doi:10.1002/14651858.CD000169.pub3. 
  • Turschner S, Efferth T (2009). “Drug resistance in Plasmodium: Natural products in the fight against malaria”, Mini Reviews in Medicinal Chemistry 9 (2), p. 206–14. doi:10.2174/138955709787316074. 
  • Meremikwu MM, Odigwe CC, Akudo Nwagbara B, Udoh EE (2012). “Antipyretic measures for treating fever in malaria”, Cochrane Database of Systematic Reviews 9, p. CD002151. doi:10.1002/14651858.CD002151.pub2. 
  • Kokwaro G (2009). “Ongoing challenges in the management of malaria”, Malaria Journal 8 (Suppl 1), p. S2. doi:10.1186/1475-2875-8-S1-S2. 
  • Keating GM (2012). “Dihydroartemisinin/piperaquine: A review of its use in the treatment of uncomplicated Plasmodium falciparum malaria”, Drugs 72 (7), p. 937–61. doi:10.2165/11203910-000000000-00000. 
  • Manyando C, Kayentao K, D'Alessandro U, Okafor HU, Juma E, Hamed K (2011). “A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy”, Malaria Journal 11, p. 141. doi:10.1186/1475-2875-11-141. 
  • O'Brien C, Henrich PP, Passi N, Fidock DA (2011). “Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum”, Current Opinion in Infectious Diseases 24 (6), p. 570–7. doi:10.1097/QCO.0b013e32834cd3ed. 
  • Fairhurst RM, Nayyar GM, Breman JG, Hallett R, Vennerstrom JL, Duong S, Ringwald P, Wellems TE, Plowe CV, Dondorp AM (2012). “Artemisinin-resistant malaria: research challenges, opportunities, and public health implications”, American Journal of Tropical Medicine and Hygiene 87 (2), p. 231–41. doi:10.4269/ajtmh.2012.12-0025. 
  • Sinclair D, Donegan S, Isba R, Lalloo DG (2012). “Artesunate versus quinine for treating severe malaria”, Cochrane Database of Systematic Reviews 6, p. CD005967. doi:10.1002/14651858.CD005967.pub4. 
  • (2014) “Challenges of drug-resistant malaria”, Parasite 21, p. 61. doi:10.1051/parasite/2014059. 
  • White NJ (2008). “Qinghaosu (artemisinin): The price of success”, Science 320 (5874), p. 330–4. doi:10.1126/science.1155165. 
  • Wongsrichanalai C, Meshnick SR (2008). “Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia–Thailand border”, Emerging Infectious Diseases 14 (5), p. 716–9. doi:10.3201/eid1405.071601. 
  • Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, von Seidlein L (2010). “Artemisinin resistance: Current status and scenarios for containment”, Nature Reviews Microbiology 8 (4), p. 272–80. doi:10.1038/nrmicro2331. 
  • (2014) “Spread of artemisinin resistance in Plasmodium falciparum malaria”, New England Journal of Medicine 371 (5), p. 411–23. doi:10.1056/NEJMoa1314981. 
  • Trampuz A, Jereb M, Muzlovic I, Prabhu R (2003). “Clinical review: Severe malaria”, Critical Care 7 (4), p. 315–23. doi:10.1186/cc2183. 
  • Fernando SD, Rodrigo C, Rajapakse S (2010). “The 'hidden' burden of malaria: Cognitive impairment following infection”, Malaria Journal 9, p. 366. doi:10.1186/1475-2875-9-366. 
  • Riley EM, Stewart VA (2013). “Immune mechanisms in malaria: New insights in vaccine development”, Nature Medicine 19 (2), p. 168–78. doi:10.1038/nm.3083. 
  • Idro R, Marsh K, John CC, Newton CRJ (2010). “Cerebral malaria: Mechanisms of brain injury and strategies for improved neuro-cognitive outcome”, Pediatric Research 68 (4), p. 267–74. doi:10.1203/PDR.0b013e3181eee738. 
  • Olupot-Olupot P, Maitland, K (2013). “Management of severe malaria: Results from recent trials”, Advances in Experimental Medicine and Biology 764, p. 241–50. doi:10.1007/978-1-4614-4726-9_20. 
  • Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD (2012). “Global malaria mortality between 1980 and 2010: A systematic analysis”, Lancet 379 (9814), p. 413–31. doi:10.1016/S0140-6736(12)60034-8. 
  • (2012) “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010”, Lancet 380 (9859), p. 2095–128. doi:10.1016/S0140-6736(12)61728-0. 
  • (16-a de septembro 2015) “The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015”, Nature 526 (7572), p. 207–211. doi:10.1038/nature15535. 
  • Guerra CA, Hay SI, Lucioparedes LS, Gikandi PW, Tatem AJ, Noor AM, Snow RW (2007). “Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project”, Malaria Journal 6 (1), p. 17. doi:10.1186/1475-2875-6-17. 
  • Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, Snow RW (2010). “Estimating the global clinical burden of Plasmodium falciparum malaria in 2007”, PLoS Medicine 7 (6), p. e1000290. doi:10.1371/journal.pmed.1000290. 
  • (2011) “A new world malaria map: Plasmodium falciparum endemicity in 2010”, Malaria Journal 10 (1), p. 378. doi:10.1186/1475-2875-10-378. 
  • Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, Greenwood BM, Sabot O, Rodriguez MH, Abeyasinghe RR, Ghebreyesus TA, Snow RW (2010). “Shrinking the malaria map: progress and prospects”, Lancet 376 (9752), p. 1566–78. doi:10.1016/S0140-6736(10)61270-6. 
  • Greenwood B, Mutabingwa T (2002). “Malaria in 2002”, Nature 415 (6872), p. 670–2. doi:10.1038/415670a. 
  • Abeku TA (2007). “Response to malaria epidemics in Africa”, Emerging Infectious Diseases 14 (5), p. 681–6. doi:10.3201/eid1305.061333. 
  • Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, Fan Q, Fang Q, Jongwutiwes S, Parker D, Sirichaisinthop J, Kyaw MP, Su XZ, Yang H, Yang Z, Wang B, Xu J, Zheng B, Zhong D, Zhou G (2012). “Malaria in the Greater Mekong Subregion: Heterogeneity and complexity”, Acta Tropica 121 (3), p. 227–39. doi:10.1016/j.actatropica.2011.02.016. 
  • Machault V, Vignolles C, Borchi F, Vounatsou P, Pages F, Briolant S, Lacaŭ JP, Rogier C (2011). “The use of remotely sensed environmental data in the study of malaria”, Geospatial Health (PDF) 5 (2), p. 151–68. doi:10.4081/gh.2011.167.  Arkivigite je 2013-03-12 per la retarkivo Wayback Machine
  • Harper K, Armelagos G (2011). “The changing disease-scape in the third epidemiological transition”, International Journal of Environmental Research and Public Health 7 (2), p. 675–97. doi:10.3390/ijerph7020675. 
  • Prugnolle F, Durand P, Ollomo B, Duval L, Ariey F, Arnathau C, Gonzalez JP, Leroy E, Renaud F (2011). “A fresh look at the origin of Plasmodium falciparum, the most malignant malaria agent”, PLoS Pathogens 7 (2), p. e1001283. doi:10.1371/journal.ppat.1001283. 
  • Cox F (2002). “History of human parasitology”, Clinical Microbiology Reviews 15 (4), p. 595–612. doi:10.1128/CMR.15.4.595-612.2002. 
  • (1999) “From Shakespeare to Defoe: malaria in England in the Little Ice Age.”, Emerging Infectious Diseases 6 (1), p. 1–11. doi:10.3201/eid0601.000101. 
  • Kaufman TS, Rúveda EA (2005). “The quest for quinine: Those who won the battles and those who won the war”, Angewandte Chemie (International Edition in English) 44 (6), p. 854–85. doi:10.1002/anie.200400663. 
  • Kyle R, Shampe M (1974). “Discoverers of quinine”, Journal of the American Medical Association 229 (4), p. 462. doi:10.1001/jama.229.4.462. 
  • Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, Rosenthal PJ, D'Alessandro U (2011). “Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria”, Malaria Journal 10 (1), p. 144. doi:10.1186/1475-2875-10-144. 
  • Hsu E (2006). “Reflections on the 'discovery' of the antimalarial qinghao”, British Journal of Clinical Pharmacology 61 (3), p. 666–70. doi:10.1111/j.1365-2125.2006.02673.x. 
  • Vogel V (2013). “Malaria as a lifesaving therapy”, Science 342 (6159), p. 684–7. doi:10.1126/science.342.6159.684. 
  • Killeen G, Fillinger U, Kiche I, Gouagna L, Knols B (2002). “Eradication of Anopheles gambiae from Brazil: Lessons for malaria control in Africa?”, Lancet Infectious Diseases 2 (10), p. 618–27. doi:10.1016/S1473-3099(02)00397-3. 
  • Vanderberg JP (2009). “Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond”, Vaccine 27 (1), p. 2–9. doi:10.1016/j.vaccine.2008.10.028. 
  • (2002) “The economic and social burden of malaria”, Nature 415 (6872), p. 680–5. doi:10.1038/415680a. 
  • Ricci F (2012). “Social implications of malaria and their relationships with poverty”, Mediterranean Journal of Hematology and Infectious Diseases 4 (1), p. e2012048. doi:10.4084/MJHID.2012.048. 
  • (2006) “Counterfeit and substandard antimalarial drugs in Cambodia”, Transactions of the Royal Society of Tropical Medicine and Hygiene 100 (11), p. 1019–24. doi:10.1016/j.trstmh.2006.01.003. 
  • (2008) “A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia”, PLoS Medicine 5 (2), p. e32. doi:10.1371/journal.pmed.0050032. 
  • (2006) “Counterfeit anti-infective drugs”, Lancet Infectious Diseases 6 (9), p. 602–13. doi:10.1016/S1473-3099(06)70581-3. 
  • Parry J (2005). “WHO combats counterfeit malaria drugs in Asia”, British Medical Journal 330 (7499), p. 1044. doi:10.1136/bmj.330.7499.1044-d. 
  • (2009) “Spurious and counterfeit drugs: A growing industry in the developing world”, Postgraduate Medical Journal 85 (1003), p. 251–6. doi:10.1136/pgmj.2008.073213. 
  • (2008) “Substandard medicines in resource-poor settings: A problem that can no longer be ignored”, Tropical Medicine & International Health 13 (8), p. 1062–72. doi:10.1111/j.1365-3156.2008.02106.x. 
  • (2012) “Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa”, Lancet Infectious Diseases 12 (6), p. 488–96. doi:10.1016/S1473-3099(12)70064-6. 
  • Williams LL (1963). “Malaria eradication in the United States”, American Journal of Public Health and the Nation's Health 53 (1), p. 17–21. doi:10.2105/AJPH.53.1.17. 
  • (2012) “History of malaria research and its contribution to the malaria control success in Suriname: A review”, Malaria Journal 11, p. 95. doi:10.1186/1475-2875-11-95. 
  • (2012) “Malaria control in Bhutan: Case study of a country embarking on elimination”, Malaria Journal 11, p. 9. doi:10.1186/1475-2875-11-9. 
  • (2009-12-01) “Malaria Control, Elimination, and Eradication: The Role of the Evolving Biomedical Research Agenda”, Journal of Infectious Diseases (en) 200 (11), p. 1639–1643. doi:10.1086/646611. 
  • Hill AVS (2011). “Vaccines against malaria”, Philosophical Transactions of the Royal Society B 366 (1579), p. 2806–14. doi:10.1098/rstb.2011.0091. 
  • (2011) “European Vaccine Initiative: Lessons from developing malaria vaccines”, Expert Review of Vaccines (PDF) 10 (12), p. 1697–708. doi:10.1586/erv.11.158. 
  • (2010) “Advances and challenges in malaria vaccine development”, Journal of Clinical Investigation 120 (12), p. 4168–78. doi:10.1172/JCI44423. 
  • (2006) “Vaccines for preventing malaria (blood-stage)”, Cochrane Database of Systematic Reviews (4), p. CD006199. doi:10.1002/14651858.CD006199. 
  • (2006) “Vaccines for preventing malaria (SPf66)”, Cochrane Database of Systematic Reviews (2), p. CD005966. doi:10.1002/14651858.CD005966. 
  • (2010) “Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria”, Human Vaccines 6 (1), p. 97–106. doi:10.4161/hv.6.1.10396. 
  • (2010) “Malaria, Plasmodium falciparum and its apicoplast”, Biochemical Society Transactions 38 (3), p. 775–82. doi:10.1042/BST0380775. 
  • (2010) “Vitamin B metabolism in Plasmodium falciparum as a source of drug targets”, Trends in Parasitology 26 (1), p. 35–43. doi:10.1016/j.pt.2009.10.006. 
  • (2011) “Thiamin (vitamin B1) biosynthesis and regulation: A rich source of antimicrobial drug targets?”, International Journal of Biological Sciences 7 (1), p. 41–52. doi:10.7150/ijbs.7.41. 
  • (2012) “The therapeutic potential of metal-based antimalarial agents: Implications for the mechanism of action”, Dalton Transactions 41 (21), p. 6335–49. doi:10.1039/C2DT12247B. 
  • (2012) “Ferrocene-based antimalarials”, Future Medicinal Chemistry 4 (6), p. 783–97. doi:10.4155/fmc.12.26. 
  • (2002) “Anopheles gambiae genome: completing the malaria triad”, Science 298 (5591), p. 13. doi:10.1126/science.298.5591.13. 
  • (2002) “Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite”, Nature 417 (6887), p. 452–5. doi:10.1038/417452a. 
  • (23a de Novembro 2015) “Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito”, Proceedings of the National Academy of Sciences, p. 201521077. doi:10.1073/pnas.1521077112. Alirita 24a de Novembro 2015.. 
  • Baird JK. (2009). “Malaria zoonoses”, Travel Medicine and Infectious Disease 7 (5), p. 269–77. doi:10.1016/j.tmaid.2009.06.004. 
  • Ameri M (2010). “Laboratory diagnosis of malaria in nonhuman primates”, Veterinary Clinical Pathology 39 (1), p. 5–19. doi:10.1111/j.1939-165X.2010.00217.x. 
  • (2008) “Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines”, Eukaryotic Cell 7 (11), p. 1875–9. doi:10.1128/EC.00242-08. 
  • (2012) “Ecology and conservation biology of avian malaria”, Annals of the New York Academy of Sciences 1249, p. 211–26. doi:10.1111/j.1749-6632.2011.06431.x. 

dx.doi.org

ebmedicine.net

euvaccine.eu

fiercebiotechresearch.com

guardian.co.uk

intechopen.com

iza.org

ftp.iza.org

  • [http://ftp.iza.org/dp2997.pdf D. Gollin D, C. Zimmermann C: Malaria - Disease Impacts and Long-Run Income Differences (angle), aŭgusto 2007, eldoninto Institute for the Study of Labor, en formato PDF

jpgmonline.com

  • Bhalla A, Suri V, Singh V (2006). “Malarial hepatopathy”, Journal of Postgraduate Medicine 52 (4), p. 315–20. 

lww.com

journals.lww.com

malariajournal.com

malariavaccine.org

nature.com

nejm.org

nobelprize.org

nytimes.com

oxfordjournals.org

jid.oxfordjournals.org

pnas.org

reuters.com

uk.reuters.com

rollbackmalaria.org

sciencemag.org

news.sciencemag.org

sma.org.sg

smj.sma.org.sg

springerlink.com

thecochranelibrary.com

theglobalfund.org

ucla.edu

ph.ucla.edu

unicef.org

unina.it

geospatialhealth.unina.it

web.archive.org

webcitation.org

who.int

who.int

whqlibdoc.who.int

wsj.com

online.wsj.com